SCHEMBL15518138

SCHEMBL15518138

O=[N+]([O-])c1ccc(Oc2ccnc(Cl)n2)c2cccnc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.58
KMT2A Q03164 12/20 0.51
MEN1 O00255 11/20 0.51
MAPT P10636 10/20 0.51
KDM4E B2RXH2 7/20 0.51
TDP1 Q9NUW8 6/20 0.51
LMNA P02545 5/20 0.51
GAA P10253 5/20 0.51
L3MBTL1 Q9Y468 5/20 0.48
HTT P42858 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
PKM P14618 3/20 0.47
HSP90AA1 P07900 2/20 0.47
OPRK1 P41145 2/20 0.47
MAPK1 P28482 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
PDE10A Q9Y233 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
PIN1 Q13526 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15516799 0.78 G6PD (0.45) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL5447146 0.78 KMT2A (0.57) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL2469901 0.76 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL2469833 0.74 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL11973409 0.71 KMT2A (0.55) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL10915347 0.71 MAPT (0.61) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL21816812 0.71 MAPT (0.61) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL12154377 0.70 MEN1 (0.57) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL20554098 0.70 GAA (0.73) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL29800743 0.70 MAPT (0.47) ALDH1A1KMT2AMEN1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796742-B2 Kinase inhibitors RESPIVERT LIMITED (GB) 2017-10-24 US disclosed
US-9732063-B2 Kinase inhibitors RESPIVERT LIMITED (GB) 2017-08-15 US disclosed
EP-2890460-B1 KINASE INHIBITORS RESPIVERT LTD (GB) 2017-02-22 EP disclosed
US-20160340375-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2016-11-24 US disclosed
EP-2925742-B1 KINASE INHIBITORS RESPIVERT LTD (GB) 2016-10-26 EP disclosed
US-20150329523-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2015-11-19 US disclosed
EP-2925742-A1 KINASE INHIBITORS Respivert Limited (GB) 2015-10-07 EP disclosed
US-20150210722-A1 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2015-07-30 US disclosed
EP-2890460-A1 KINASE INHIBITORS Respivert Limited (GB) 2015-07-08 EP disclosed
WO-2014076484-A1 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2014-05-22 WO disclosed
WO-2014033446-A1 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2014-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210722-A1 KINASE INHIBITORS SYK, SRC, LYN ALDH1A1 2702/4885KMT2A 2457/4885MEN1 4580/4885
US-20160340375-A1 KINASE INHIBITORS SYK, LYN, BTK ALDH1A1 2639/4885KMT2A 2476/4885MEN1 4489/4885
US-20150329523-A1 KINASE INHIBITORS SYK, SRC, BTK ALDH1A1 4202/4885KMT2A 3728/4885MEN1 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.